ANDA 74795, held by Teva Parenteral Medicines. Fluphenazine Decanoate.
As of Nov 21, 2026, ANDA 74795 (Fluphenazine Decanoate), held by Teva Parenteral Medicines, was first approved by FDA on Sep 10, 1996, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 10, 1996 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluphenazine Decanoate25MG/ML · injectable;injection | Fluphenazine Decanoate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters